.

Karyopharm Therapeutics reported $82.59M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Abbvie ABBV:US $ 11288M 2467M
Amgen AMGN:US $ 4.42B 680M
Astrazeneca AZN:US 10.23B 280M
AstraZeneca AZN:LN 840.42B 39.99B
Avrobio Inc AVRO:US 27.77M 1.64M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Bristol Myers Squibb BMY:US $ 9.3B 202M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Epizyme EPZM:US $ 57.33M 2.29M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Johnson & Johnson JNJ:US $ 18.18B 616M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Macrogenics MGNX:US $ 67.82M 9.92M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NVS:US 10.86B 895M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Takeda 4502:JP 821.95B 52.96B
Tg Therapeutics TGTX:US $ 39.53M 29.35M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Xencor XNCR:US $ 58.18M 854K
YTE INCY:US $ 656.97M 40.27M